Search
for
Sort by
Research 30 of 1000+
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- An update of anti-viral treatment of COVID-19
- Interferon in the treatment of cutaneous T-cell lymphoma
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- Immunomodulators in the treatment of cutaneous lymphoma
- Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- Medical Therapies
- Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- INTERFERONS IN DERMATOLOGY
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
- Plasmacytoid dendritic cells in alopecia areata: missing link?